Navigation Links
The Queen Of All Contraceptives Released

A few months back, the Food and Drug Administration approved a new birth control pill, Lybrel. It is as effective at preventing pregnancy as the other pills already in the market , but overrides them with one advantage: Women who take it will never get their periods.

Lybrel is landing on pharmacy shelves this month. Now menstruation may never be the same- it may disappear altogether.

Already the first few volleys in this battle have been exchanged, a barrage of advertising and research highlighting the debilitating effects of periods and the joys of menstrual suppression.

Women libbers may argue- periods and their mood swings are bad for family values (cranky mothers), bad for womens health, bad for the fashion industry and bad for the economy (leave taken on grounds of period pain).

In a presentation by Lybrels maker, Wyeth, to investors and analysts last October, Dr. Ginger D. Constantine, the companys therapeutic director for womens health, laid the groundwork. Citing company-backed studies, she reported that menstruating women feel less effective at work and take more sick days. Not only that, but they dont exercise and they wear dark clothes more often, she said.

Suddenly, news articles are weighing the pros and cons of the monthly cycles. Yet, history shows that such debates are, well, cyclical. In the 1870s and 1880s, when Americans were debating the value of higher education for women, a flurry of research asserted that womens cycling constitutions made them unfit for sustained mental and physical labor.

Henry Maudsley, a British doctor, reflected popular opinion when he observed that menstruation doomed girls to failure in college. Comparing boys and girls, Maudsley insisted in an article, was not a question of two bodies and minds that are in equal physical condition, but of one body and mind capable of sustained and regular hard labor, and of another body and mind which one quarter of each month, during the best years of life, is more or less sick and unfit for hard work.

After women pressed ahead, attended college and excelled in the halls of learning, the debate about menstrual cycles shifted from their suitability for higher education to their suitability for public life in general. When the suffragists asked to participate in the political process, experts retaliated with more research proving that women belonged in the domestic sphere; menstruation figured prominently among the reasons.

Once women won the right to vote in 1920, the menstruation-equals-inadequacy debate waned for a while. In fact, two decades later, new proof arrived that women were perfectly fit and capable (even when bleeding) and therefore should step right up and join the war effort. But after the war, a fresh batch of studies were released proving that children need their moms at home, that the workplace is potentially hazardous to womens unborn children and that womens cycles make them less efficient workers than men.

In any case, the present debate against such a pill is not a particularly profitable attitude for Wyeth, as it angles for its share of the $1.7 billion annual American market for birth control pills.

So as business-savvy officials re-conceptualize menstruation as a disease in need of treatment, bleeding women may well be in for a lot of confusion- to stop or not to?


'"/>




Related medicine news :

1. Beauty Queens Urge On The Importance Of Maintaining Bone Integrity
2. Queensland Bans OTC Sales Of Cold And Flu Drugs
3. Queensland Opposition not happy over hiring consultancy
4. The mystery of the bulge in North Queenslanders
5. Queensland : Call for improved mental health services
6. Surgery cancellations in Queens land Hospital
7. Mammograms in Queensland Reviewed
8. Queensland Government to Meet its Medical Targets
9. Meningococcal Scare in Queensland
10. Medical Person As Health Minister To Improve Queenslands Health System
11. Dentist Tested Positive For HIV - Queensland Health To Screen Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: